(Q53307878)

13 May 2018

editorial

0 references

review article

1 reference

title

International application of the incidence rate/window period model. (English)

1 reference

13 May 2018

4

Michael P Busch

1 reference

13 May 2018

Simone A Glynn

1

1 reference

13 May 2018

Steven H Kleinman

series ordinal

2

1 reference

13 May 2018

David J Wright

series ordinal

3

1 reference

13 May 2018

NHLBI Retrovirus Epidemiology Donor Study

series ordinal

5

1 reference

13 May 2018

publication date

1 August 2002

1 reference

13 May 2018

published in

Transfusion

1 reference

13 May 2018

volume

42

1 reference

13 May 2018

issue

8

1 reference

13 May 2018

page(s)

966-972

1 reference

13 May 2018

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Estimated risk of transfusion-transmitted viral infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Immune response to blood transfusion invery-low-birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

HIV seroconverting donors delay their return: screening test implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Epidemiology of hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Pathogen inactivation of labile blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

Estimated risk of HIV transmission by blood transfusion in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00200.X

10.1046/J.1537-2995.2002.00200.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018